Skip to main content

Table 3 Histopathology of malignant and benign nodules

From: Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.

HP of malignant nodules (n = 147) Number of nodules (%)
Adenocarcinoma 59 (40)
Squamous cell carcinoma 40 (27)
Large cell cancer 11 (7.5)
Carcinoid tumor 11 (7.5)
Non-specified NSCLC 9 (6.1)
Small cell lung cancer 8 (5.4)
Other 9 (6.1)
HP of benign nodules (n = 55)  
Non-specified benign 10 (18)
Fibrosis-elastosis 9 (16)
Chronic inflammation 7 (13)
Lymphoid tissue hyperplasia 4 (7.2)
Squamous metaplasia 4 4 (7.2)
Granuloma 3 (5.5)
Atypical cytology 3 (5.5)
Tuberculosis 3 (5.5)
Rheumatoid nodules 2 (3.6)
Silicoanthracotic nodules 2 (3.6)
Cryptococcus infection 2 (3.6)
Other 6 (11)
  1. HP = Histopathology